HS90B_HUMAN - dbPTM
HS90B_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID HS90B_HUMAN
UniProt AC P08238
Protein Name Heat shock protein HSP 90-beta
Gene Name HSP90AB1
Organism Homo sapiens (Human).
Sequence Length 724
Subcellular Localization Cytoplasm . Melanosome . Nucleus . Secreted . Cell membrane . Identified by mass spectrometry in melanosome fractions from stage I to stage IV (PubMed:17081065). Translocates with BIRC2 from the nucleus to the cytoplasm during differentiation (PubMed
Protein Description Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Undergoes a functional cycle that is linked to its ATPase activity. This cycle probably induces conformational changes in the client proteins, thereby causing their activation. Interacts dynamically with various co-chaperones that modulate its substrate recognition, ATPase cycle and chaperone function. [PubMed: 16478993]
Protein Sequence MPEEVHHGEEEVETFAFQAEIAQLMSLIINTFYSNKEIFLRELISNASDALDKIRYESLTDPSKLDSGKELKIDIIPNPQERTLTLVDTGIGMTKADLINNLGTIAKSGTKAFMEALQAGADISMIGQFGVGFYSAYLVAEKVVVITKHNDDEQYAWESSAGGSFTVRADHGEPIGRGTKVILHLKEDQTEYLEERRVKEVVKKHSQFIGYPITLYLEKEREKEISDDEAEEEKGEKEEEDKDDEEKPKIEDVGSDEEDDSGKDKKKKTKKIKEKYIDQEELNKTKPIWTRNPDDITQEEYGEFYKSLTNDWEDHLAVKHFSVEGQLEFRALLFIPRRAPFDLFENKKKKNNIKLYVRRVFIMDSCDELIPEYLNFIRGVVDSEDLPLNISREMLQQSKILKVIRKNIVKKCLELFSELAEDKENYKKFYEAFSKNLKLGIHEDSTNRRRLSELLRYHTSQSGDEMTSLSEYVSRMKETQKSIYYITGESKEQVANSAFVERVRKRGFEVVYMTEPIDEYCVQQLKEFDGKSLVSVTKEGLELPEDEEEKKKMEESKAKFENLCKLMKEILDKKVEKVTISNRLVSSPCCIVTSTYGWTANMERIMKAQALRDNSTMGYMMAKKHLEINPDHPIVETLRQKAEADKNDKAVKDLVVLLFETALLSSGFSLEDPQTHSNRIYRMIKLGLGIDEDEVAAEEPNAAVPDEIPPLEGDEDASRMEEVD
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
25SulfoxidationQAEIAQLMSLIINTF
HHHHHHHHHHHHHHH
1.7228183972
31PhosphorylationLMSLIINTFYSNKEI
HHHHHHHHHCCCHHH
17.3421945579
33NitrationSLIINTFYSNKEIFL
HHHHHHHCCCHHHHH
14.86-
33PhosphorylationSLIINTFYSNKEIFL
HHHHHHHCCCHHHHH
14.8621945579
34PhosphorylationLIINTFYSNKEIFLR
HHHHHHCCCHHHHHH
36.9221945579
36AcetylationINTFYSNKEIFLREL
HHHHCCCHHHHHHHH
46.3772623285
36UbiquitinationINTFYSNKEIFLREL
HHHHCCCHHHHHHHH
46.3721906983
45PhosphorylationIFLRELISNASDALD
HHHHHHHHCHHHHHH
38.6820164059
48PhosphorylationRELISNASDALDKIR
HHHHHCHHHHHHHHC
27.8928152594
53AcetylationNASDALDKIRYESLT
CHHHHHHHHCHHHCC
29.9025953088
53UbiquitinationNASDALDKIRYESLT
CHHHHHHHHCHHHCC
29.9021890473
56NitrationDALDKIRYESLTDPS
HHHHHHCHHHCCCHH
17.22-
56PhosphorylationDALDKIRYESLTDPS
HHHHHHCHHHCCCHH
17.2227273156
58PhosphorylationLDKIRYESLTDPSKL
HHHHCHHHCCCHHHC
27.8625159151
60PhosphorylationKIRYESLTDPSKLDS
HHCHHHCCCHHHCCC
55.9625159151
63PhosphorylationYESLTDPSKLDSGKE
HHHCCCHHHCCCCCE
48.9721815630
64AcetylationESLTDPSKLDSGKEL
HHCCCHHHCCCCCEE
62.8022640955
64UbiquitinationESLTDPSKLDSGKEL
HHCCCHHHCCCCCEE
62.8021890473
67PhosphorylationTDPSKLDSGKELKID
CCHHHCCCCCEEEEE
63.3030108239
69AcetylationPSKLDSGKELKIDII
HHHCCCCCEEEEEEC
64.9223749302
69UbiquitinationPSKLDSGKELKIDII
HHHCCCCCEEEEEEC
64.9221890473
72AcetylationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.1527452117
72SuccinylationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.1523954790
72SumoylationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.15-
72UbiquitinationLDSGKELKIDIIPNP
CCCCCEEEEEECCCH
39.15-
83PhosphorylationIPNPQERTLTLVDTG
CCCHHCCEEEEEECC
24.2820873877
85PhosphorylationNPQERTLTLVDTGIG
CHHCCEEEEEECCCC
24.9120873877
89PhosphorylationRTLTLVDTGIGMTKA
CEEEEEECCCCCCHH
24.1829514088
93SulfoxidationLVDTGIGMTKADLIN
EEECCCCCCHHHHHH
3.0828183972
94PhosphorylationVDTGIGMTKADLINN
EECCCCCCHHHHHHH
20.1921712546
95UbiquitinationDTGIGMTKADLINNL
ECCCCCCHHHHHHHH
30.8921890473
104PhosphorylationDLINNLGTIAKSGTK
HHHHHHHHHHHHHHH
22.4125159151
107MalonylationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.6426320211
107UbiquitinationNNLGTIAKSGTKAFM
HHHHHHHHHHHHHHH
45.6421890473
108PhosphorylationNLGTIAKSGTKAFME
HHHHHHHHHHHHHHH
42.5530624053
110PhosphorylationGTIAKSGTKAFMEAL
HHHHHHHHHHHHHHH
26.7028464451
111UbiquitinationTIAKSGTKAFMEALQ
HHHHHHHHHHHHHHH
43.05-
114SulfoxidationKSGTKAFMEALQAGA
HHHHHHHHHHHHCCC
3.3528183972
124PhosphorylationLQAGADISMIGQFGV
HHCCCCEEEEECCCC
12.61-
125SulfoxidationQAGADISMIGQFGVG
HCCCCEEEEECCCCH
4.0028183972
148UbiquitinationEKVVVITKHNDDEQY
EEEEEEECCCCCCCE
29.3221906983
155PhosphorylationKHNDDEQYAWESSAG
CCCCCCCEEEECCCC
16.1928152594
159PhosphorylationDEQYAWESSAGGSFT
CCCEEEECCCCCEEE
18.1321964256
160PhosphorylationEQYAWESSAGGSFTV
CCEEEECCCCCEEEE
21.2925693802
164PhosphorylationWESSAGGSFTVRADH
EECCCCCEEEEEECC
19.4721964256
166PhosphorylationSSAGGSFTVRADHGE
CCCCCEEEEEECCCC
15.6924719451
177MethylationDHGEPIGRGTKVILH
CCCCCCCCCCEEEEE
50.78115479847
179PhosphorylationGEPIGRGTKVILHLK
CCCCCCCCEEEEEEC
22.3021964256
180SumoylationEPIGRGTKVILHLKE
CCCCCCCEEEEEECC
30.06-
180UbiquitinationEPIGRGTKVILHLKE
CCCCCCCEEEEEECC
30.0621906983
186AcetylationTKVILHLKEDQTEYL
CEEEEEECCCHHHHH
48.8030583301
186MethylationTKVILHLKEDQTEYL
CEEEEEECCCHHHHH
48.8030583301
186UbiquitinationTKVILHLKEDQTEYL
CEEEEEECCCHHHHH
48.8021906983
190PhosphorylationLHLKEDQTEYLEERR
EEECCCHHHHHHHHH
38.6328152594
192PhosphorylationLKEDQTEYLEERRVK
ECCCHHHHHHHHHHH
23.8527273156
196MethylationQTEYLEERRVKEVVK
HHHHHHHHHHHHHHH
39.04-
204AcetylationRVKEVVKKHSQFIGY
HHHHHHHHHHHHCCC
36.5626051181
204UbiquitinationRVKEVVKKHSQFIGY
HHHHHHHHHHHHCCC
36.5621890473
206PhosphorylationKEVVKKHSQFIGYPI
HHHHHHHHHHCCCCE
35.3528152594
211PhosphorylationKHSQFIGYPITLYLE
HHHHHCCCCEEEEEH
6.1428152594
214PhosphorylationQFIGYPITLYLEKER
HHCCCCEEEEEHHHH
12.5928152594
216PhosphorylationIGYPITLYLEKEREK
CCCCEEEEEHHHHHH
12.2628152594
219AcetylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.5223236377
219SuccinylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.52-
219SuccinylationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.5223954790
219UbiquitinationPITLYLEKEREKEIS
CEEEEEHHHHHHCCC
60.5221890473
226PhosphorylationKEREKEISDDEAEEE
HHHHHCCCHHHHHHH
39.8519664994
237AcetylationAEEEKGEKEEEDKDD
HHHHHCCCCCCCCCC
78.1921339330
237UbiquitinationAEEEKGEKEEEDKDD
HHHHHCCCCCCCCCC
78.1921906983
255PhosphorylationPKIEDVGSDEEDDSG
CCHHCCCCCCCCCCC
41.5219664994
261PhosphorylationGSDEEDDSGKDKKKK
CCCCCCCCCCCCHHH
61.1329255136
263AcetylationDEEDDSGKDKKKKTK
CCCCCCCCCCHHHHH
71.0323236377
263UbiquitinationDEEDDSGKDKKKKTK
CCCCCCCCCCHHHHH
71.03-
269PhosphorylationGKDKKKKTKKIKEKY
CCCCHHHHHHHHHHH
46.5826074081
273UbiquitinationKKKTKKIKEKYIDQE
HHHHHHHHHHHCCHH
57.97-
275AcetylationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3726051181
275MethylationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.37129319
275UbiquitinationKTKKIKEKYIDQEEL
HHHHHHHHHCCHHHH
42.3721906983
276NitrationTKKIKEKYIDQEELN
HHHHHHHHCCHHHHH
15.72-
276PhosphorylationTKKIKEKYIDQEELN
HHHHHHHHCCHHHHH
15.7225159151
284AcetylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2322640947
284MalonylationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2326320211
284UbiquitinationIDQEELNKTKPIWTR
CCHHHHHCCCCCCCC
71.2321906983
285PhosphorylationDQEELNKTKPIWTRN
CHHHHHCCCCCCCCC
40.7623401153
286AcetylationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.79-
286MethylationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.7942353157
286UbiquitinationQEELNKTKPIWTRNP
HHHHHCCCCCCCCCC
35.7921906983
290PhosphorylationNKTKPIWTRNPDDIT
HCCCCCCCCCCCCCC
22.6829978859
291MethylationKTKPIWTRNPDDITQ
CCCCCCCCCCCCCCH
37.37115479887
297PhosphorylationTRNPDDITQEEYGEF
CCCCCCCCHHHHHHH
36.6017525332
301PhosphorylationDDITQEEYGEFYKSL
CCCCHHHHHHHHHHH
22.6221712546
305PhosphorylationQEEYGEFYKSLTNDW
HHHHHHHHHHHCCCH
8.7228796482
306AcetylationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.2926822725
306SumoylationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.29-
306UbiquitinationEEYGEFYKSLTNDWE
HHHHHHHHHHCCCHH
44.2921906983
307PhosphorylationEYGEFYKSLTNDWED
HHHHHHHHHCCCHHH
29.1030266825
309PhosphorylationGEFYKSLTNDWEDHL
HHHHHHHCCCHHHCE
37.9230266825
319AcetylationWEDHLAVKHFSVEGQ
HHHCEEEEEEEEECE
33.07156797
319UbiquitinationWEDHLAVKHFSVEGQ
HHHCEEEEEEEEECE
33.0721906983
322PhosphorylationHLAVKHFSVEGQLEF
CEEEEEEEEECEEEE
20.9827251275
347AcetylationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.7925953088
347MalonylationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.7926320211
347MethylationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.79-
347UbiquitinationPFDLFENKKKKNNIK
CCCCCCCCCCCCCCE
59.79-
348AcetylationFDLFENKKKKNNIKL
CCCCCCCCCCCCCEE
79.2530583295
348UbiquitinationFDLFENKKKKNNIKL
CCCCCCCCCCCCCEE
79.25-
350UbiquitinationLFENKKKKNNIKLYV
CCCCCCCCCCCEEEE
65.20-
354AcetylationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.5712421637
354MalonylationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.5726320211
354UbiquitinationKKKKNNIKLYVRRVF
CCCCCCCEEEEEEEE
35.5721906983
363SulfoxidationYVRRVFIMDSCDELI
EEEEEECCCCHHHHH
1.7928465586
365O-linked_GlycosylationRRVFIMDSCDELIPE
EEEECCCCHHHHHHH
13.1923301498
365PhosphorylationRRVFIMDSCDELIPE
EEEECCCCHHHHHHH
13.1921406692
366GlutathionylationRVFIMDSCDELIPEY
EEECCCCHHHHHHHH
4.0322555962
373PhosphorylationCDELIPEYLNFIRGV
HHHHHHHHHHHHHCC
11.1127251275
383PhosphorylationFIRGVVDSEDLPLNI
HHHCCCCCCCCCCCC
22.7720873877
387AcetylationVVDSEDLPLNISREM
CCCCCCCCCCCCHHH
35.3719608861
387UbiquitinationVVDSEDLPLNISREM
CCCCCCCCCCCCHHH
35.3719608861
391PhosphorylationEDLPLNISREMLQQS
CCCCCCCCHHHHHHH
22.5530266825
398PhosphorylationSREMLQQSKILKVIR
CHHHHHHHHHHHHHH
14.5429116813
399N6-malonyllysineREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
399AcetylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9522640939
399MalonylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.9526320211
399SumoylationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
399UbiquitinationREMLQQSKILKVIRK
HHHHHHHHHHHHHHH
47.95-
402AcetylationLQQSKILKVIRKNIV
HHHHHHHHHHHHHHH
38.8026051181
411AcetylationIRKNIVKKCLELFSE
HHHHHHHHHHHHHHH
32.9126051181
411MalonylationIRKNIVKKCLELFSE
HHHHHHHHHHHHHHH
32.9126320211
411UbiquitinationIRKNIVKKCLELFSE
HHHHHHHHHHHHHHH
32.9121890473
412S-nitrosocysteineRKNIVKKCLELFSEL
HHHHHHHHHHHHHHH
2.71-
412GlutathionylationRKNIVKKCLELFSEL
HHHHHHHHHHHHHHH
2.7122555962
412S-nitrosylationRKNIVKKCLELFSEL
HHHHHHHHHHHHHHH
2.7120140087
417PhosphorylationKKCLELFSELAEDKE
HHHHHHHHHHHHCHH
44.3021406692
423AcetylationFSELAEDKENYKKFY
HHHHHHCHHHHHHHH
39.0926822725
423UbiquitinationFSELAEDKENYKKFY
HHHHHHCHHHHHHHH
39.09-
426PhosphorylationLAEDKENYKKFYEAF
HHHCHHHHHHHHHHH
19.3521406692
427AcetylationAEDKENYKKFYEAFS
HHCHHHHHHHHHHHH
48.2425953088
427UbiquitinationAEDKENYKKFYEAFS
HHCHHHHHHHHHHHH
48.24-
428AcetylationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.7027178108
428SuccinylationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.7023954790
428UbiquitinationEDKENYKKFYEAFSK
HCHHHHHHHHHHHHH
42.7021890473
430PhosphorylationKENYKKFYEAFSKNL
HHHHHHHHHHHHHHC
18.4128152594
433AcetylationYKKFYEAFSKNLKLG
HHHHHHHHHHHCCCC
7.7419608861
433UbiquitinationYKKFYEAFSKNLKLG
HHHHHHHHHHHCCCC
7.7419608861
434O-linked_GlycosylationKKFYEAFSKNLKLGI
HHHHHHHHHHCCCCC
27.90UniProtKB CARBOHYD
434PhosphorylationKKFYEAFSKNLKLGI
HHHHHHHHHHCCCCC
27.9030266825
435AcetylationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9019608861
435MalonylationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9026320211
435MethylationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9019608861
435UbiquitinationKFYEAFSKNLKLGIH
HHHHHHHHHCCCCCC
60.9021890473
438AcetylationEAFSKNLKLGIHEDS
HHHHHHCCCCCCCCC
54.8025953088
438UbiquitinationEAFSKNLKLGIHEDS
HHHHHHCCCCCCCCC
54.8021890473
445PhosphorylationKLGIHEDSTNRRRLS
CCCCCCCCCCHHHHH
25.2923401153
446PhosphorylationLGIHEDSTNRRRLSE
CCCCCCCCCHHHHHH
45.1030266825
452O-linked_GlycosylationSTNRRRLSELLRYHT
CCCHHHHHHHHHHHH
25.12UniProtKB CARBOHYD
452PhosphorylationSTNRRRLSELLRYHT
CCCHHHHHHHHHHHH
25.1228355574
457PhosphorylationRLSELLRYHTSQSGD
HHHHHHHHHHCCCCC
14.9328152594
459PhosphorylationSELLRYHTSQSGDEM
HHHHHHHHCCCCCCC
21.3728152594
460PhosphorylationELLRYHTSQSGDEMT
HHHHHHHCCCCCCCC
14.7228152594
462PhosphorylationLRYHTSQSGDEMTSL
HHHHHCCCCCCCCHH
48.2328152594
466SulfoxidationTSQSGDEMTSLSEYV
HCCCCCCCCHHHHHH
3.5221406390
467PhosphorylationSQSGDEMTSLSEYVS
CCCCCCCCHHHHHHH
25.1928152594
468PhosphorylationQSGDEMTSLSEYVSR
CCCCCCCHHHHHHHH
28.7027422710
470PhosphorylationGDEMTSLSEYVSRMK
CCCCCHHHHHHHHHH
27.0128152594
472PhosphorylationEMTSLSEYVSRMKET
CCCHHHHHHHHHHHH
10.5928152594
474PhosphorylationTSLSEYVSRMKETQK
CHHHHHHHHHHHHHC
26.2528152594
475MethylationSLSEYVSRMKETQKS
HHHHHHHHHHHHHCC
30.10115479895
477AcetylationSEYVSRMKETQKSIY
HHHHHHHHHHHCCEE
57.4023749302
477UbiquitinationSEYVSRMKETQKSIY
HHHHHHHHHHHCCEE
57.4019913553
479PhosphorylationYVSRMKETQKSIYYI
HHHHHHHHHCCEEEE
35.4623312004
481AcetylationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.3619608861
481MalonylationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.3626320211
481UbiquitinationSRMKETQKSIYYITG
HHHHHHHCCEEEECC
46.3621890473
482PhosphorylationRMKETQKSIYYITGE
HHHHHHCCEEEECCC
13.1525159151
484NitrationKETQKSIYYITGESK
HHHHCCEEEECCCCH
8.91-
484PhosphorylationKETQKSIYYITGESK
HHHHCCEEEECCCCH
8.9127273156
485PhosphorylationETQKSIYYITGESKE
HHHCCEEEECCCCHH
7.1327794612
487PhosphorylationQKSIYYITGESKEQV
HCCEEEECCCCHHHH
20.8325348954
490PhosphorylationIYYITGESKEQVANS
EEEECCCCHHHHHHH
42.7228152594
491AcetylationYYITGESKEQVANSA
EEECCCCHHHHHHHH
48.1123954790
491UbiquitinationYYITGESKEQVANSA
EEECCCCHHHHHHHH
48.1121906983
497PhosphorylationSKEQVANSAFVERVR
CHHHHHHHHHHHHHH
17.2228985074
505AcetylationAFVERVRKRGFEVVY
HHHHHHHHCCCEEEE
54.7526051181
505UbiquitinationAFVERVRKRGFEVVY
HHHHHHHHCCCEEEE
54.75-
506MethylationFVERVRKRGFEVVYM
HHHHHHHCCCEEEEE
44.46115479879
512PhosphorylationKRGFEVVYMTEPIDE
HCCCEEEEECCCCCH
11.9620068231
513SulfoxidationRGFEVVYMTEPIDEY
CCCEEEEECCCCCHH
2.0130846556
514PhosphorylationGFEVVYMTEPIDEYC
CCEEEEECCCCCHHH
22.4120068231
520AcetylationMTEPIDEYCVQQLKE
ECCCCCHHHHHHHHH
8.3219608861
520PhosphorylationMTEPIDEYCVQQLKE
ECCCCCHHHHHHHHH
8.3225884760
520UbiquitinationMTEPIDEYCVQQLKE
ECCCCCHHHHHHHHH
8.3219608861
521GlutathionylationTEPIDEYCVQQLKEF
CCCCCHHHHHHHHHC
1.7822555962
521S-palmitoylationTEPIDEYCVQQLKEF
CCCCCHHHHHHHHHC
1.7826865113
526AcetylationEYCVQQLKEFDGKSL
HHHHHHHHHCCCCCC
52.5825953088
526UbiquitinationEYCVQQLKEFDGKSL
HHHHHHHHHCCCCCC
52.58-
531AcetylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3223954790
531MethylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3224880080
531SuccinylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.32-
531SuccinylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3221906983
531SumoylationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.32-
531UbiquitinationQLKEFDGKSLVSVTK
HHHHCCCCCCEEEEH
42.3221890473
532PhosphorylationLKEFDGKSLVSVTKE
HHHCCCCCCEEEEHH
39.2630266825
535PhosphorylationFDGKSLVSVTKEGLE
CCCCCCEEEEHHCCC
29.3930266825
537PhosphorylationGKSLVSVTKEGLELP
CCCCEEEEHHCCCCC
18.8330266825
538AcetylationKSLVSVTKEGLELPE
CCCEEEEHHCCCCCC
47.8623236377
538UbiquitinationKSLVSVTKEGLELPE
CCCEEEEHHCCCCCC
47.8621890473
550AcetylationLPEDEEEKKKMEESK
CCCCHHHHHHHHHHH
62.0626051181
550UbiquitinationLPEDEEEKKKMEESK
CCCCHHHHHHHHHHH
62.0621906983
551AcetylationPEDEEEKKKMEESKA
CCCHHHHHHHHHHHH
61.7126051181
551UbiquitinationPEDEEEKKKMEESKA
CCCHHHHHHHHHHHH
61.71-
552UbiquitinationEDEEEKKKMEESKAK
CCHHHHHHHHHHHHH
63.71-
553SulfoxidationDEEEKKKMEESKAKF
CHHHHHHHHHHHHHH
10.6930846556
556PhosphorylationEKKKMEESKAKFENL
HHHHHHHHHHHHHHH
25.3028258704
559AcetylationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.8823749302
559MethylationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.8870059
559UbiquitinationKMEESKAKFENLCKL
HHHHHHHHHHHHHHH
57.8821890473
564S-nitrosylationKAKFENLCKLMKEIL
HHHHHHHHHHHHHHH
4.852212679
565AcetylationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5723749302
565MalonylationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5726320211
565MethylationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5742353145
565UbiquitinationAKFENLCKLMKEILD
HHHHHHHHHHHHHHH
55.5721906983
568AcetylationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6323749302
568MalonylationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6326320211
568UbiquitinationENLCKLMKEILDKKV
HHHHHHHHHHHHHCC
52.6321890473
573UbiquitinationLMKEILDKKVEKVTI
HHHHHHHHCCEEEEE
56.10-
574AcetylationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.1223749302
574MethylationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.1224880080
574SuccinylationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.1223954790
574UbiquitinationMKEILDKKVEKVTIS
HHHHHHHCCEEEEEC
56.12-
577AcetylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.9025953088
577SuccinylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.90-
577SuccinylationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.9027452117
577UbiquitinationILDKKVEKVTISNRL
HHHHCCEEEEECCCC
47.90-
579PhosphorylationDKKVEKVTISNRLVS
HHCCEEEEECCCCCC
29.7423312004
581PhosphorylationKVEKVTISNRLVSSP
CCEEEEECCCCCCCC
13.4123312004
586PhosphorylationTISNRLVSSPCCIVT
EECCCCCCCCEEEEE
32.9021945579
587PhosphorylationISNRLVSSPCCIVTS
ECCCCCCCCEEEEEE
17.9321945579
590S-nitrosocysteineRLVSSPCCIVTSTYG
CCCCCCEEEEEECCC
2.96-
590GlutathionylationRLVSSPCCIVTSTYG
CCCCCCEEEEEECCC
2.9622555962
590S-nitrosylationRLVSSPCCIVTSTYG
CCCCCCEEEEEECCC
2.9619696785
593PhosphorylationSSPCCIVTSTYGWTA
CCCEEEEEECCCCHH
8.7421945579
594PhosphorylationSPCCIVTSTYGWTAN
CCEEEEEECCCCHHC
14.5621945579
595PhosphorylationPCCIVTSTYGWTANM
CEEEEEECCCCHHCH
19.3821945579
596NitrationCCIVTSTYGWTANME
EEEEEECCCCHHCHH
15.50-
596PhosphorylationCCIVTSTYGWTANME
EEEEEECCCCHHCHH
15.5021945579
599PhosphorylationVTSTYGWTANMERIM
EEECCCCHHCHHHHH
12.0921945579
602SulfoxidationTYGWTANMERIMKAQ
CCCCHHCHHHHHHHH
3.2130846556
607AcetylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.677289923
607MethylationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.67-
607UbiquitinationANMERIMKAQALRDN
HCHHHHHHHHHHHCC
34.6721906983
612MethylationIMKAQALRDNSTMGY
HHHHHHHHCCCHHHH
44.04-
615PhosphorylationAQALRDNSTMGYMMA
HHHHHCCCHHHHHHH
24.8621945579
616PhosphorylationQALRDNSTMGYMMAK
HHHHCCCHHHHHHHH
22.3721945579
617SulfoxidationALRDNSTMGYMMAKK
HHHCCCHHHHHHHHH
3.4830846556
619PhosphorylationRDNSTMGYMMAKKHL
HCCCHHHHHHHHHHC
3.4821945579
620SulfoxidationDNSTMGYMMAKKHLE
CCCHHHHHHHHHHCC
1.4228465586
621SulfoxidationNSTMGYMMAKKHLEI
CCHHHHHHHHHHCCC
3.5828465586
623AcetylationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8823954790
623MalonylationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8826320211
623MethylationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8823748837
623UbiquitinationTMGYMMAKKHLEINP
HHHHHHHHHHCCCCC
23.8821890473
624AcetylationMGYMMAKKHLEINPD
HHHHHHHHHCCCCCC
43.8316916647
624UbiquitinationMGYMMAKKHLEINPD
HHHHHHHHHCCCCCC
43.8321890473
637PhosphorylationPDHPIVETLRQKAEA
CCCHHHHHHHHHHHH
19.1528985074
639MethylationHPIVETLRQKAEADK
CHHHHHHHHHHHHCC
43.29115479871
641UbiquitinationIVETLRQKAEADKND
HHHHHHHHHHHCCCC
41.58-
649UbiquitinationAEADKNDKAVKDLVV
HHHCCCCHHHHHHHH
65.5521906983
669PhosphorylationALLSSGFSLEDPQTH
HHHHCCCCCCCCCCH
34.0820068231
685UbiquitinationNRIYRMIKLGLGIDE
HHHHHHHHHCCCCCH
27.4521906983
718PhosphorylationLEGDEDASRMEEVD-
CCCCCCHHHCCCCC-
44.4729255136
720SulfoxidationGDEDASRMEEVD---
CCCCHHHCCCCC---
4.8230846556

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
89TPhosphorylationKinasePNCKQ6P2M8
GPS
89TPhosphorylationKinasePKACAP17612
PSP
226SPhosphorylationKinaseCK2_GROUP-PhosphoELM
226SPhosphorylationKinaseCSK21P68400
PhosphoELM
226SPhosphorylationKinaseCK2-FAMILY-GPS
226SPhosphorylationKinaseCSNK2A1P33674
GPS
255SPhosphorylationKinaseAURKBQ96GD4
GPS
255SPhosphorylationKinaseCK2_GROUP-PhosphoELM
255SPhosphorylationKinaseCK2-FAMILY-GPS
255SPhosphorylationKinaseCSNK2A1P33674
GPS
255SPhosphorylationKinaseCSK21P68400
PhosphoELM
301YPhosphorylationKinaseSRCP12931
Uniprot
452SPhosphorylationKinaseAURKBQ96GD4
GPS
718SPhosphorylationKinaseCK1AP48729
PSP
718SPhosphorylationKinaseGSK3BP49841
PSP
718SPhosphorylationKinasePLK2Q9NYY3
Uniprot
718SPhosphorylationKinasePLK3Q9H4B4
Uniprot
718SPhosphorylationKinaseCK2A1P68400
PSP

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference
226SPhosphorylation

15581363
255SPhosphorylation



Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of HS90B_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
HS90A_HUMANHSP90AA1physical
20353823
KPCE_HUMANPRKCEphysical
20353823
FGFR3_HUMANFGFR3physical
21487019
RS6_HUMANRPS6physical
22939629
RL6_HUMANRPL6physical
22939629
MYH9_HUMANMYH9physical
22939629
RL17_HUMANRPL17physical
22939629
RL14_HUMANRPL14physical
22939629
RL7A_HUMANRPL7Aphysical
22939629
RS2_HUMANRPS2physical
22939629
RS26_HUMANRPS26physical
22939629
RS23_HUMANRPS23physical
22939629
RL32_HUMANRPL32physical
22939629
RL10A_HUMANRPL10Aphysical
22939629
RS16_HUMANRPS16physical
22939629
RL3_HUMANRPL3physical
22939629
STIP1_HUMANSTIP1physical
22939629
MYL6_HUMANMYL6physical
22939629
IF4A1_HUMANEIF4A1physical
22939629
STML2_HUMANSTOML2physical
22939629
MCM5_HUMANMCM5physical
22939629
VATB2_HUMANATP6V1B2physical
22939629
SMD1_HUMANSNRPD1physical
22939629
WASL_HUMANWASLphysical
15791211
TCPA_HUMANTCP1physical
16263121
HS105_HUMANHSPH1physical
16263121
PRKDC_HUMANPRKDCphysical
16263121
GNAI2_HUMANGNAI2physical
16263121
XPO1_HUMANXPO1physical
16263121
KPYM_HUMANPKMphysical
16263121
G3P_HUMANGAPDHphysical
16263121
PGK1_HUMANPGK1physical
16263121
LDHA_HUMANLDHAphysical
16263121
ALDOA_HUMANALDOAphysical
16263121
MDHC_HUMANMDH1physical
16263121
C1TC_HUMANMTHFD1physical
16263121
SERC_HUMANPSAT1physical
16263121
FAS_HUMANFASNphysical
16263121
SIAS_HUMANNANSphysical
16263121
ACTG_HUMANACTG1physical
16263121
TPM3_HUMANTPM3physical
16263121
FLNA_HUMANFLNAphysical
16263121
MYH9_HUMANMYH9physical
16263121
SPTN1_HUMANSPTAN1physical
16263121
NUMA1_HUMANNUMA1physical
16263121
ACTN1_HUMANACTN1physical
16263121
UBA1_HUMANUBA1physical
16263121
PSMD1_HUMANPSMD1physical
16263121
PSB5_HUMANPSMB5physical
16263121
SYAC_HUMANAARSphysical
16263121
EF2_HUMANEEF2physical
16263121
EIF3H_HUMANEIF3Hphysical
16263121
RLA0_HUMANRPLP0physical
16263121
RS6_HUMANRPS6physical
16263121
RS4X_HUMANRPS4Xphysical
16263121
RL7_HUMANRPL7physical
16263121
RS3A_HUMANRPS3Aphysical
16263121
RL5_HUMANRPL5physical
16263121
SYIM_HUMANIARS2physical
16263121
RSSA_HUMANRPSAphysical
16263121
AHSA1_HUMANAHSA1physical
20226818
MK07_HUMANMAPK7physical
23428871
CDC37_HUMANCDC37physical
23428871
CHRD1_MOUSEChordc1physical
15642353
SGTA_HUMANSGTAphysical
21988832
TEBP_HUMANPTGES3physical
21988832
CSN4_HUMANCOPS4physical
22863883
MCM2_HUMANMCM2physical
22863883
MVP_HUMANMVPphysical
22863883
HS90A_HUMANHSP90AA1physical
25036637
CC117_HUMANCCDC117physical
25036637
PPP5_HUMANPPP5Cphysical
25036637
TTC4_HUMANTTC4physical
25036637
CHIP_HUMANSTUB1physical
25036637
TOM34_HUMANTOMM34physical
25036637
FKBP5_HUMANFKBP5physical
25036637
CDC37_HUMANCDC37physical
25036637
FKBP4_HUMANFKBP4physical
25036637
AHSA1_HUMANAHSA1physical
25036637
HGH1_HUMANHGH1physical
25036637
TBA1A_HUMANTUBA1Aphysical
25036637
TEBP_HUMANPTGES3physical
25036637
STIP1_HUMANSTIP1physical
25036637
TMOD4_HUMANTMOD4physical
25036637
CYBP_HUMANCACYBPphysical
25036637
AIP_HUMANAIPphysical
25036637
HS90B_HUMANHSP90AB1physical
10543959
CD37L_HUMANCDC37L1physical
25416956
AHSA1_HUMANAHSA1physical
26344197
ATPA_HUMANATP5A1physical
26344197
CALR_HUMANCALRphysical
26344197
OST48_HUMANDDOSTphysical
26344197
DNJA2_HUMANDNAJA2physical
26344197
G3P_HUMANGAPDHphysical
26344197
HSP74_HUMANHSPA4physical
26344197
HSP7C_HUMANHSPA8physical
26344197
CH60_HUMANHSPD1physical
26344197
CH10_HUMANHSPE1physical
26344197
IPO7_HUMANIPO7physical
26344197
NPM3_HUMANNPM3physical
26344197
PDIA1_HUMANP4HBphysical
26344197
SSRD_HUMANSSR4physical
26344197
STIP1_HUMANSTIP1physical
26344197
TBB5_HUMANTUBBphysical
26344197
RL40_HUMANUBA52physical
26344197
QCR2_HUMANUQCRC2physical
26344197
TRAF2_HUMANTRAF2physical
25241761
IKKB_HUMANIKBKBphysical
25241761
GNAI2_HUMANGNAI2physical
25241761
FLNA_HUMANFLNAphysical
25241761
NFKB1_HUMANNFKB1physical
25241761
HSF1_HUMANHSF1physical
26517842
HIF1A_HUMANHIF1Aphysical
26517842
ERR2_HUMANESRRBphysical
26517842
MET_HUMANMETphysical
26517842
KEAP1_HUMANKEAP1physical
26517842
RHBT2_HUMANRHOBTB2physical
26517842
EGLN1_HUMANEGLN1physical
23413029
TEBP_HUMANPTGES3physical
21183720
EGLN1_HUMANEGLN1physical
24711448
SRC_HUMANSRCphysical
28215707
FANCA_HUMANFANCAphysical
28215707
CDC37_HUMANCDC37physical
28215707
SODC_HUMANSOD1physical
28215707
AHSA1_HUMANAHSA1physical
25486457
CDC37_HUMANCDC37physical
25486457

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of HS90B_HUMAN

loading...

Related Literatures of Post-Translational Modification
Acetylation
ReferencePubMed
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions.";
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.;
Science 325:834-840(2009).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-275; LYS-284; LYS-354;LYS-399; LYS-402; LYS-435; LYS-481 AND LYS-568, AND MASS SPECTROMETRY.
"Substrate and functional diversity of lysine acetylation revealed bya proteomics survey.";
Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.;
Mol. Cell 23:607-618(2006).
Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-624, AND MASS SPECTROMETRY.
Malonylation
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-399.
N6-malonyllysine
ReferencePubMed
"The first identification of lysine malonylation substrates and itsregulatory enzyme.";
Peng C., Lu Z., Xie Z., Cheng Z., Chen Y., Tan M., Luo H., Zhang Y.,He W., Yang K., Zwaans B.M., Tishkoff D., Ho L., Lombard D., He T.C.,Dai J., Verdin E., Ye Y., Zhao Y.;
Mol. Cell. Proteomics 10:M111.012658.01-M111.012658.12(2011).
Cited for: MALONYLATION AT LYS-399.
Phosphorylation
ReferencePubMed
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions.";
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.;
Sci. Signal. 2:RA46-RA46(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography.";
Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.;
Proteomics 8:1346-1361(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"A quantitative atlas of mitotic phosphorylation.";
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255; SER-261;SER-307; SER-452; SER-532 AND SER-718, AND MASS SPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255 ANDSER-261, AND MASS SPECTROMETRY.
"Phosphorylation analysis of primary human T lymphocytes usingsequential IMAC and titanium oxide enrichment.";
Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
J. Proteome Res. 7:5167-5176(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-261, AND MASSSPECTROMETRY.
"Phosphoproteome of resting human platelets.";
Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,Schuetz C., Walter U., Gambaryan S., Sickmann A.;
J. Proteome Res. 7:526-534(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Toward a global characterization of the phosphoproteome in prostatecancer cells: identification of phosphoproteins in the LNCaP cellline.";
Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
Electrophoresis 28:2027-2034(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Phosphoproteome analysis of the human mitotic spindle.";
Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.;
Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization.";
Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
Nat. Biotechnol. 24:1285-1292(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226; SER-255 ANDSER-261, AND MASS SPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-226 AND SER-255, ANDMASS SPECTROMETRY.
"Quantitative phosphoproteome analysis using a dendrimer conjugationchemistry and tandem mass spectrometry.";
Tao W.A., Wollscheid B., O'Brien R., Eng J.K., Li X.-J.,Bodenmiller B., Watts J.D., Hood L., Aebersold R.;
Nat. Methods 2:591-598(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Phosphoproteomic analysis of synaptosomes from human cerebralcortex.";
DeGiorgis J.A., Jaffe H., Moreira J.E., Carlotti C.G. Jr., Leite J.P.,Pant H.C., Dosemeci A.;
J. Proteome Res. 4:306-315(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255, AND MASSSPECTROMETRY.
"Large-scale characterization of HeLa cell nuclear phosphoproteins.";
Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.;
Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-255 AND SER-261, ANDMASS SPECTROMETRY.
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage.";
Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.;
Science 316:1160-1166(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-297, AND MASSSPECTROMETRY.
"An extensive survey of tyrosine phosphorylation revealing new sitesin human mammary epithelial cells.";
Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,Wiley H.S., Qian W.-J.;
J. Proteome Res. 8:3852-3861(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-484, AND MASSSPECTROMETRY.
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer.";
Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
Cell 131:1190-1203(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-484, AND MASSSPECTROMETRY.
"Immunoaffinity profiling of tyrosine phosphorylation in cancercells.";
Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.;
Nat. Biotechnol. 23:94-101(2005).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-484, AND MASSSPECTROMETRY.

TOP